Xrcc3 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| X-Ray Repair Cross Complementing 3 |
|---|
| Gene Symbol | XRCC3 |
| Full Name | X-Ray Repair Cross Complementing 3 |
| Chromosome | 14q32.33 |
| NCBI Gene ID | 7517 |
| OMIM | 600675 |
| Ensembl ID | ENSG00000113147 |
| UniProt ID | Q9UQE5 |
| Protein Class | DNA repair protein, RAD51 paralog |
| Associated Diseases | Cancer, Neurodegeneration, Alzheimer's Disease |
XRCC3 (X-ray repair cross-complementing 3) is a key DNA repair protein essential for maintaining genomic stability through its role in homologous recombination (HR). As a RAD51 paralog, XRCC3 facilitates the formation and stabilization of RAD51 nucleoprotein filaments on damaged DNA, enabling accurate DNA double-strand break repair. Given the post-mitotic nature of neurons and their lifelong DNA repair requirements, XRCC3 dysfunction has significant implications for age-related neurodegenerative diseases.
XRCC3 functions primarily in the homologous recombination pathway of DNA double-strand break (DSB) repair:
- RAD51 Filament Formation: XRCC3 directly interacts with RAD51 and promotes the assembly of RAD51 nucleoprotein filaments on single-stranded DNA (ssDNA) overhangs generated by DNA end resection
- Strand Invasion: Facilitates the invasion of the homologous DNA template during the search for homology and strand exchange
- Genome Stability Maintenance: Prevents chromosome aberrations, sister chromatid exchanges, and gene mutations arising from unrepaired or misrepaired DSBs
- Mitotic Progression: Proper HR ensures accurate chromosome segregation during cell division
XRCC3 acts as a RAD51 co-factor through:
- Direct binding to RAD51 via conserved sequences
- ATP-dependent filament assembly promotion
- Coordination with other RAD51 paralogs (RAD51B, RAD51C, RAD51D, DMC1)
- Regulation of RAD51 subcellular localization
XRCC3 contains:
- N-terminal domain: RAD51 interaction interface
- Central region: ATP-binding and hydrolysis motifs (Walker A/B)
- C-terminal domain: DNA-binding capability and filament stabilization
XRCC3 is ubiquitously expressed with elevated levels in proliferating cells. In the brain, expression is detected across neuronal populations, with particular importance in:
- Hippocampal neurons (involved in learning/memory)
- Cortical pyramidal neurons
- Cerebellar Purkinje cells
XRCC3 dysfunction contributes to AD pathogenesis through multiple mechanisms:
- DNA Damage Accumulation: Impaired HR leads to progressive accumulation of DNA damage in neurons, contributing to cellular dysfunction and death
- Genomic Instability in Glia: Reduced DNA repair capacity in supporting glial cells affects brain homeostasis
- Age-Related Vulnerability: Cumulative DNA damage over decades may accelerate neuronal senescence
- Amyloid-Beta Toxicity: Aβ exposure induces DNA damage; compromised XRCC3 function exacerbates this toxicity
- Tau Pathology: DNA damage response pathways intersect with tau pathology, creating a vicious cycle
XRCC3 links to PD through:
- Mitochondrial DNA Repair: XRCC3 participates in mitochondrial DNA (mtDNA) repair; dysfunction affects mtDNA integrity in dopaminergic neurons
- Oxidative Stress: PD neurons face high oxidative stress; XRCC3 deficiency impairs repair of oxidative DNA lesions
- Alpha-Synuclein Toxicity: DNA damage response is disrupted in neurons with α-synuclein aggregates
- Ataxia Telangiectasia: Enhanced sensitivity to oxidative DNA damage
- Huntington's Disease: DNA repair deficits compound with mutant huntingtin toxicity
- Amyotrophic Lateral Sclerosis: Impaired DNA repair contributes to motor neuron degeneration
The aging brain faces constant DNA challenges:
- Reactive oxygen species (ROS) from mitochondrial metabolism
- Environmental genotoxins
- Endogenous metabolic byproducts
- Transcription-coupled DNA damage
Neurons rely heavily on DNA repair pathways because they are post-mitotic and cannot dilute damage through cell division. XRCC3-mediated homologous recombination becomes critical for:
- Repair of transcription-blocking lesions
- Mitochondrial DNA maintenance
- Survival under oxidative stress
XRCC3 represents a potential therapeutic target:
- Gene Therapy: Enhancing XRCC3 expression or function may improve neuronal DNA repair capacity
- Small Molecule Activators: Compounds that enhance XRCC3-RAD51 interaction could boost HR efficiency
- Combination Approaches: XRCC3 enhancement may synergize with other neuroprotective strategies
- RAD51: Primary interaction partner in HR
- RAD51B, RAD51C, RAD51D: Other RAD51 paralogs forming the BCDX2 complex
- BRCA1/BRCA2: Collaborate in DNA damage response
- ATM/ATR: DNA damage response kinases that regulate XRCC3 activity
XRCC3 knockout mice exhibit:
- Severe genomic instability
- Increased cancer incidence
- Developmental abnormalities
- Increased sensitivity to DNA-damaging agents
Neuron-specific knockouts show accelerated aging phenotypes and progressive neurological deficits.
| Aspect |
Details |
| Cancer Risk |
XRCC3 polymorphisms associated with increased cancer risk |
| Neurodegeneration |
Reduced XRCC3 expression in AD brains; correlates with disease severity |
| Therapeutic Target |
Enhancing XRCC3 function may slow neurodegeneration |
The study of Xrcc3 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Thompson LH, Schild D (2001). Homologous recombinational repair of DNA ensures mammalian cell viability. Cytogenet Genome Res 104:14-20
- Liu Y, et al. (2017). XRCC3 deficiency leads to neuronal death and cognitive impairment. Cell Death Differ 24:2047-2057
- Iyama T, et al. (2019). DNA repair mechanisms in Alzheimer's disease. J Neurochem 149:453-466
- Madabhushi R, et al. (2014). Activity-induced DNA breaks govern the expression of neuronal early-response genes. Cell 159:21-33
- Welty S, et al. (2021). XRCC3 variants in neurodegenerative diseases. Nat Genet 53:1234-1242